Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective.
about
Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.Chloroquine Sensitizes Nasopharyngeal Carcinoma Cells but Not Nasoepithelial Cells to Irradiation by Blocking AutophagymiR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinomaPathologic aspects of skull base tumors.Cigarette smoking complements the prognostic value of baseline plasma Epstein-Barr virus deoxyribonucleic acid in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy: a large-scale retrospective cohort study.Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma.MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1.NOS1 S-nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells.Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.T4/N2 classification nasopharyngeal carcinoma benefit from concurrent chemotherapy in the era of intensity-modulated radiotherapy.Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response.Magnetic Resonance Imaging-Detected Tumor Residue after Intensity-Modulated Radiation Therapy and its Association with Post-Radiation Plasma Epstein-Barr Virus Deoxyribonucleic Acid in Nasopharyngeal Carcinoma.MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma.Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma.The increased expression of TCF3 is correlated with poor prognosis in Chinese patients with nasopharyngeal carcinoma.Expression of chemokine receptor CXCR4 is closely correlated with clinical outcome in human nasopharyngeal carcinoma.Investigational drugs for nasopharyngeal carcinoma.STYK1 promotes Warburg effect through PI3K/AKT signaling and predicts a poor prognosis in nasopharyngeal carcinoma.LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis.Low-grade nasopharyngeal papillary adenocarcinoma: a case report and review of the literature.The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.A National Study of Survival Trends and Conditional Survival in Nasopharyngeal Carcinoma: Analysis of the National Population-Based Surveillance Epidemiology and End Results Registry.Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas.Lymph node standardized uptake values at pre-treatment 18F-fluorodeoxyglucose positron emission tomography as a valuable prognostic factor for distant metastasis in nasopharyngeal carcinoma.Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinomaGenetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients.Cervical nodal volume for prognostication and risk stratification of patients with nasopharyngeal carcinoma, and implications on the TNM-staging system.Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy.Cetuximab and Cisplatin Show Different Combination Effect in Nasopharyngeal Carcinoma Cells Lines via Inactivation of EGFR/AKT Signaling Pathway.Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.Nasopharyngeal carcinoma presenting as an inconspicuous primary lesion with extensive cavernous sinus involvement and temporal lobe extension: a case report and review of literatureCD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma.High pretreatment serum gamma-glutamyl transpeptidase predicts an inferior outcome in nasopharyngeal carcinoma.Elevated pretreatment platelet distribution width and platelet count predict poor prognosis in nasopharyngeal carcinoma.RANK expression in EBV positive nasopharyngeal carcinoma metastasis: a ready-to-treat target?Cytomembranic PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma.Radiation-resistant cancer stem-like cell properties are regulated by PTEN through the activity of nuclear β-catenin in nasopharyngeal carcinoma.
P2860
Q30235263-E19B1604-E415-4B9E-AE1C-33FCC1544452Q36201710-CBDCB49B-3093-42E7-A4B9-D16F280F68D1Q36208147-41663A37-1531-4C90-85CC-3D6ADCCC5991Q36775043-BE420B98-07AB-41D3-92F9-6ECB5EBE0442Q36985110-3FC4EA14-FD76-4D9E-B7B8-9A5B1A7362FCQ37086130-99F3EB90-13E7-4CE2-B8F4-CF99A20ADA4DQ37269257-4EAF4136-5799-4DA0-B467-1284E8620198Q37469803-4F135A50-A478-473D-8752-CA22277B2510Q37645814-9B18A61D-2661-459B-92EF-69E330ACAC9FQ37652356-02B351CF-62D6-4ABD-B56A-0C47821BE18FQ37678950-652ABF69-E49D-4661-A8E9-A6DEC17E23A2Q37697250-FCE4F3B3-DECC-4D90-92A6-F205AC78C2AFQ37705026-0BFF7ADE-D89F-45EE-BFE5-CC1D97364819Q37738097-C1844B73-14E8-4CC8-84A2-4F8890609440Q37744968-EC40353B-06AB-41DF-9D5D-B0C0804A6358Q38376092-E4DB7365-3EBE-4413-87F3-23B8634BE9C3Q38376290-95A74A50-7A7A-4EA6-8341-CEF8F5DB40E6Q38649545-0D0B9A10-C8F7-40A4-ADC4-F5128A7735FBQ38690528-472D304D-CFBB-46B1-9700-9A02850A67D0Q38696915-2A145894-837A-4722-AB24-6F05390FF79BQ38709621-4ECBC73F-1C67-437F-8EBF-EDC0872294F0Q38858662-DA2DF938-B7E2-4113-B235-5AE0BA067994Q39344275-7D768A4D-3711-43FA-A45D-52BA41D9D082Q40237173-1A24D92A-058C-4137-ADE0-3E594A88C8DAQ40323714-C2B3EAFD-1313-40A3-B26A-FC5A8A21D981Q40324400-A9D749C6-562F-4314-A1B5-36F9B4AB9FE4Q40410720-2E1A708A-762F-4DA4-A766-E75A2883E078Q40983645-DC7AAA30-24C6-434A-AFC0-D2AB259D17BAQ41436597-4D10FD4C-24A7-4328-B6CD-B225FB9E3868Q41606792-EA67D858-F9D7-4A17-8DF1-1FF85667281AQ41695908-F1AC00D6-CCB2-4198-B1FA-0A3AC36AC940Q41852684-C0AAF274-D880-4B27-A321-F3C9DA18D8C6Q42133579-C287F7D3-D69E-405D-992D-EDC6169CF9A3Q42279542-60064E88-2184-4AC1-8805-2F6EF3000CBAQ42366441-3D528913-77B8-408A-BA31-E864F4120B0CQ42366562-B2147030-8093-4CE7-9B3A-DC06A9127EFBQ47103406-65CEADB8-728E-4532-9AC9-3E654EBAB90DQ47106594-4DE860EE-EE4D-4AC8-8465-8FCC0273F6C1Q47129284-53443DC1-4ECA-4EFB-A692-654C1D0D4664Q47140610-791BFFEE-2D82-45A1-94D4-0D126D7D294D
P2860
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective.
@en
type
label
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective.
@en
prefLabel
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective.
@en
P2093
P50
P356
P1476
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
@en
P2093
Anne W M Lee
Anthony T C Chan
Brigette B Y Ma
Wai Tong Ng
P304
P356
10.1200/JCO.2015.60.9347
P407
P577
2015-09-08T00:00:00Z